Frontiers in Life Sciences: Investment & Financing Roadshow Recruitment Now Open!

As the global life sciences sector flourishes, artificial intelligence and big data are increasingly converging with life sciences. Coupled with the implementation of the Biosecurity Law of the People’s Republic of China, the biotechnology industry is poised to seize unprecedented development opportunities, while also generating substantial business prospects for the life sciences field. Against the backdrop of a continuous rise in domestic clinical trials and the rapid expansion of the biopharmaceutical industry, the scale of China’s life sciences sector continues to grow, with market demand maintaining a robust growth trajectory.

Suzhou New District is the only region in Jiangsu Province’s “One Zone, One Industry” strategic layout that receives key support for the development of the medical device industry., alsoIt is one of the “two cores” that Suzhou is striving to build as a landmark for its biopharmaceutical industry. After more than 10 years of development, the district’s medical device and biopharmaceutical industries have achieved rapid clustering and high-speed growth., driving the industry's output value toward the trillion-yuan mark and accelerating the formation of an internationally renowned and domestically first-class industrial cluster.

Against this backdrop, VCBeat joined forces with Suzhou New DistrictHosting the “Frontiers in Life Sciences” Investment and Financing Roadshow, Inviting Companies in IVD Raw Materials, Biological Reagents, and Analytical Instruments, collaborating with leading industry enterprises, investment institutions, and industrial parks to jointly explore breakthrough strategies and future development trends in the field of life sciences consumables, thereby empowering the rapid growth of the life sciences industry.

Over a Dozen Life Sciences Companies Deliver Compelling Roadshows

Over a dozen life sciences companies, including Xuanyu Medical, Aibo Medical Robotics, Agile Intelligent Manufacturing, Yangqi Medical Chip, Puguang Biotech, Aiwan Medicine, Jiangtai Biotech, Weiji Gene, Juyuan Biotech, Weigong Biotech, Shuzhi Yuanyu, and Dilan Biotech, kicked off their roadshows to showcase cutting-edge technologies in the life sciences sector.

Interactive Exchange with Over 20 Investment Institutions

At the roadshow, heads of more than twenty investment institutions—including SND Investment, Tan Zhen Capital, Qiangyun Capital, Hanyu Capital, Inno Angel Fund, Fortune Capital, CAS Star, Sherpa Capital, Yiyun Capital, Beijing Science and Technology Innovation Investment Management Co., Ltd., Essence Securities Investment, and Proxima Ventures—attended to engage in on-site exchanges and discussions on investment opportunities in the life sciences sector.

Thursday, December 7, 2023, 9:00–17:00

Room 310, Building 1, Jiangsu Medical Device Technology Industrial Park, No. 8 Jinfeng Road, Huqiu District, Suzhou City, Jiangsu Province, China

Scan the QR code to register!

※ This event is an offline roadshow, divided into morning and afternoon sessions, with each session limited to 80 attendees.

Suzhou New District High-Tech Investment Promotion Center Co., Ltd. was established in November 2020. As a state-owned enterprise directly under the Administration Committee of Suzhou New District, it oversees three subsidiaries: Suzhou New District High-Tech Sci-Tech Innovation Angel Venture Capital Management Co., Ltd., Suzhou New District High-Tech Achievement Transformation Co., Ltd., and Suzhou New District High-Tech Intellectual Property Services Co., Ltd. Anchored by its core responsibility of leading and coordinating technology-focused investment promotion across the entire district, and aligning with the “2+5” industrial system of Suzhou New District, the company has developed a business model centered on attracting sci-tech innovation resources, while synergistically advancing angel investments in sci-tech startups, transformation of scientific and technological achievements, and intellectual property services.

Jiangsu Medical Device Science and Technology Industrial ParkConstruction commenced in 2009, with a total planned area of 2 square kilometers and an existing total gross floor area of self-built facilities nearing 1 million square meters., is a national-level medical device technology industrial park jointly established by Suzhou High-Tech Zone and the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, with Suzhou Medical Device Industry Development Group Co., Ltd. serving as the operating entity,Upholding the development philosophy of “Integration and Innovation,” with ““ecological development, industrial cluster formation, investment promotion through funds, specialized services, market-oriented platforms, self-held carriers, asset securitization, and digitalized operations and maintenance” operational model,Establishing Medpark as the Leading Domestic Brand in the Medical Device IndustryBuild a medical device industrial base with an output value of over RMB 100 billion.

VCBeat, founded in 2014, is a novel industry service provider that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and accelerate the growth of industry innovators. It offers services such as brand communication, research consulting, data monitoring, and resource/project matchmaking to enterprises, government industrial parks, investment institutions, and other stakeholders across the industry chain.

This is a service under VCBeat that focuses on integrating brand building with performance-driven marketing and conversion. It features columns and events such as “Open Courses,” “New Product Reviews,” and “Government-Enterprise Exchange Meetings.” Leveraging VCBeat’s reachable network of 300,000 professionals in the innovative healthcare sector, the service helps enterprises rapidly promote innovative products and services and precisely identify potential target partners through rigorous topic and product selection, professional content planning, and precise, effective outreach.